S
ymptomatic aortic stenosis is a devastating disease with a poor prognosis if left untreated. 1 Conventional measures of lesion severity of these patients have relied on the presence of a low aortic valve area and high mean gradient in the setting of normal transvalvular flow. Nonetheless, recent reports have demonstrated that many patients with aortic stenosis may have low gradient (mean, <40 mm Hg), severe aortic stenosis (LGSAS; aortic valve area, <1.0 cm 2 ) despite the presence of a normal ejection fraction (EF>50%). 2 The natural history of this entity (also known as paradoxical low flow, LGSAS) is debated, although some studies have demonstrated features similar to aortic stenosis with low cardiac output and low EF, and a markedly impaired survival among those treated medically compared with patients that undergo aortic valve replacement. 3 
Clinical Perspective on p 710
The pathophysiology of low flow, LGSAS is poorly understood. Proposed mechanisms include the presence of a relatively smaller left ventricular (LV) chamber and reduced stroke volume, resulting in lower transvalvular flow and aortic valve gradient. The cause of reduced stroke volume has been attributed to intrinsic myocardial dysfunction (despite preserved EF) and elevated global LV afterload attributable to the combination of a stenotic valve and arterial impedance. [3] [4] [5] [6] Abnormalities of arterial afterload are common in elderly patients, the population most susceptible to degenerative calcific aortic stenosis. Thus, isolated measurements of the aortic valve gradient and valve area without consideration of arterial properties may not accurately reflect the burden on the left ventricle.
Accordingly, the present investigation examined alterations in afterload through invasive assessment of effective arterial elastance (Ea), total arterial compliance (Ca), and peripheral arterial resistance (systemic vascular resistance index [SVRI] ) in patients with LGSAS.
Methods

Patients
The Mayo Clinic Institutional Review Board approved this study. Using the medical record of patients seen at Mayo Clinic (Rochester, MN) between January 1, 2006, and August 1, 2012, we identified 36 adult patients (≥18 years) with LGSAS (mean, <40 mm Hg; aortic valve area, <1.0 cm 2 or aortic valve area index, <0.6 cm 2 /m 2 ) with preserved EF (≥50%) detected by transthoracic echocardiography who also underwent an invasive hemodynamic study within 90 days of echocardiography. Patients with moderate or severe concomitant valvular heart disease (ie, aortic, mitral, or Background-The pathophysiology of low flow, low gradient severe aortic stenosis (LGSAS) with preserved ejection fraction is poorly understood. It has been proposed that abnormalities of arterial circulation are a major contributor to this syndrome. Methods and Results-We invasively examined systemic arterial afterload (effective arterial elastance, Ea; total arterial compliance, Ca; and systemic vascular resistance index) in patients with LGSAS (mean gradient, <40 mm Hg; aortic valve area, <1.0 cm 2 ) and preserved ejection fraction (≥50%), and compared these findings with patients with high gradient (≥40 mm Hg) severe aortic stenosis (HGSAS) and moderate AS (mean gradient, <40 mm Hg; aortic valve area, >1.0 cm 2 ). Patients with LGSAS (n=36), HGSAS (n=31), and moderate AS (n=19) were similar with respect to age, sex, body size, symptoms, comorbidities, and ejection fraction. Aortic valve area was similar between groups with LGSAS and HGSAS, but the patients with LGSAS had reduced stroke volume index and cardiac index (P=0.003 for both 7, 8 Blood pressure was measured at the time of echocardiography by manual sphygmomanometer. Cardiac rhythm was measured by electrocardiography at the time of echocardiography. All studies were reviewed for data on cardiac chamber morphology and function, concomitant valvular and structural disease, estimations of pulmonary artery pressure, diastolic function, and the assessment of aortic stenosis as previously described. 7, 8 LV outflow tract diameter was measured in the parasternal long axis view in early systole from the point of aortic cusp insertion into the interventricular septum to the point of aortic cusp insertion into the intervalvular fibrosa. LV stroke volume was derived from Doppler interrogation of the LV outflow tract. 7 For each study, a nonimaging probe was used in multiple transducer positions (apical, suprasternal, supraclavicular, subcostal, and right parasternal) to record the maximal aortic jet velocity for calculation of transvalvular pressure gradient and aortic valve area. For patients in nonsinus rhythm, 10 cardiac cycles were averaged to obtain echocardiographic data.
Invasive Hemodynamic Evaluation
All patients underwent hemodynamic left and right heart catheterization in the fasting state using conventional 6 and 7 French fluid-filled catheters. Invasive hemodynamic measurements were obtained before any pharmacological or physical maneuvers or fluid administration. LV end-systolic pressure was measured by examining individual simultaneous aortic and LV tracings, and identifying the point of crossover between aortic and LV pressures. For aortic valve assessment, simultaneous pressures were taken from 2 separate sampling catheters in the central aorta and LV with digital acquisition (3-5 ms samples) for offline storage and review using proprietary software (CathCoding; Mayo Clinic, Rochester, MN). Cardiac output was determined by the thermodilution technique or by the Fick method, indexed to body surface area, and was used to determine stroke volume index. For the Fick method, oxygen consumption was measured by expired gas analysis at the time of catheterization (Medical Graphics Corporation, St. Paul, MN). The Gorlin formula was used to calculate aortic valve area. 
Invasive Assessment of Afterload
Effective arterial elastance (Ea), a lumped measure of arterial load that combines the effects of resistive and pulsatile loading, was calculated from the ratio of LV end-systolic pressure (mm Hg) to stroke volume index (mL/m 2 ). [10] [11] [12] Total systemic arterial compliance (Ca) was calculated from the ratio of stroke volume index to aortic pulse pressure.
13,14 SVRI (dyn·s·m 2 /cm 5 ) was calculated from (mean aortic pressure-mean right atrial pressure×80)÷cardiac index (L/min per m 2 ). LV afterload can also be conceptualized by wall stress. To contrast between measures of arterial afterload (above) and total LV afterload, circumferential end-systolic wall stress was determined from 2D echocardiographic LV chamber dimensions (internal, external, and midwall radii) and directly measured LV end-systolic pressure. 15 
Statistical Analysis
Comparison of continuous data was made using an unpaired Student t test. Categorical clinical variables were compared between the 2 groups using the χ 2 test or Fisher exact test where appropriate. Invasive measures of afterload in low and high gradient severe and moderate aortic stenoses. Effective arterial elastance (Ea) and systemic vascular resistance index (SVRI) were significantly higher in patients with low gradient severe aortic stenosis (LGSAS) compared with patients with high gradient severe aortic stenosis (HGSAS) and moderate aortic stenosis (AS), whereas total arterial compliance (Ca) was reduced in LGSAS compared with HGSAS and moderate AS. Circumferential end-systolic wall stress (cESS) was similar between
LGSAS and HGSAS, and lower in moderate AS.
One-way ANOVA was used for comparisons between moderate AS, LGSAS, and high gradient severe aortic stenosis (HGSAS). Linear regression analysis was used to examine correlation between individual variables. Sensitivity and specificity with binomial approximation intervals were calculated for diagnosis of LGSAS using identified cutoff values. Statistical analysis was performed using SPSS (SAS software version 12.0, Cary, NC). Statistical significance was set a priori as P<0.05.
Results
Patient Characteristics
Hypertension was present in the vast majority of patients (>75%), whereas diabetes mellitus, chronic lung disease, coronary artery disease, and atrial fibrillation also were common (Table 1) . Patients with LGSAS had lower mean aortic valve gradients compared with patients with HGSAS. There were no differences in age, cardiac chamber dimensions, EF, and noninvasive measures of diastolic function among patients with LGSAS, HGSAS, and moderate AS.
Afterload in LGSAS, HGSAS, and Moderate AS
Invasive hemodynamic data are shown in Table 2 Figure 1 ). All measures of afterload were inversely related to stroke volume index in the groups with LGSAS, HGSAS, and moderate AS (Figure 2 ). All correlations for afterload and stroke volume index remained significant when patients with LGSAS were examined alone (P<0.001 for all). Ea correlated with mean gradient in patients with LGSAS alone (r=-0.40; P=0.008) but less with SVRI (r=-0.19; P=0.12) and Ca (r=0.20; P=0.12). Overall, stroke volume index was modestly related with aortic pulse pressure (r=0.20; P=0.05) and aortic valve mean gradient (r=0.25; P=0.01; Figure 3 ), but not significantly related to LV end-systolic pressure (r=0.05; P=0.34). There were no significant correlations between aortic valve area and measures of afterload. Representative invasive hemodynamic tracings of patients with LGSAS and HGSAS are shown in Figure 4 .
For differentiating LGSAS versus moderate AS according to afterload, cutoff levels associated with LGSAS were identified for Ea, Ca, and SVRI. Ea ≥3. 
Clinical Course
During the study period, surgical aortic valve replacement was performed in 18 (58%) patients with HGSAS, 16 (44%) with LGSAS, and 6 (32%) patients with moderate AS. Transcatheter aortic valve replacement was performed in 7 (23%) patients with HGSAS, 2 (6%) with LGSAS, and in none of the patients with moderate AS. Death occurred during the study period in 7 (23%) patients with HGSAS, 5 (14%) with LGSAS, and 3 (16%) patients with moderate AS.
Discussion
The principal finding of the present investigation is the demonstration of elevated arterial afterload, despite similar endsystolic wall stress in patients with LGSAS in comparison with patients with HGSAS and moderate AS. Patients with LGSAS displayed abnormally elevated Ea and peripheral arterial resistance, and reduced Ca. The elevation in Ea was associated with reduced stroke volume index, cardiac index, and mean aortic valve gradient. These results support the hypothesis that low flow, LGSAS with preserved EF is a syndrome characterized by abnormal arterial load combined with calcific aortic valve stenosis, leading to discordant valve area and flow-dependent measurements, such as aortic gradient and peak velocity.
Patients with LGSAS had relatively lower stroke volume index and cardiac output despite similar LVEF and signs of less advanced aortic stenosis (less LV hypertrophy and lower diastolic filling pressure) in comparison with the patients with HGSAS. These abnormalities have been reported in previous studies of LGSAS, where the transvalvular flow generated is seemingly paradoxically reduced. Our study demonstrates that ventricular afterload, as determined by arterial elastance and systemic resistance, is elevated in LGSAS. The effects of abnormal Ea, arterial compliance, and peripheral resistance distal to aortic stenosis are additive with the valvular resistance to increase the overall load against which the LV must contract. The lower forward output leads to a lower transvalvular aortic gradient despite the presence of significant aortic stenosis. Of note, the present study was performed with direct invasive measurements of the aortic valve gradient and cardiac output, obviating concerns that measurement error may account for discrepancies in the assessment of LGSAS when noninvasive methods are used. Although recent noninvasive studies have shown that patients with LGSAS may have elevated arterial afterload, this is the first study to demonstrate this invasively, without inherent measurement errors that may occur because of underestimation of the LV outflow tract diameter, misplacement of pulsed-wave Doppler sample volume, 16 inherent inconsistencies in guideline cutoffs for aortic valve area attributable to body size and LV outflow tract diameter, 17 and noninvasive measurement of arterial afterload using estimation of LV end-systolic pressure and blood pressure by manual sphygmomanometer. 5 Our observations provide insight into the paradoxical nature of this entity, where a lower aortic valve gradient may occur despite the presence of significant aortic stenosis. Reduced stroke volume has been implicated as a contributing cause of the entity of LGSAS. Stroke volume index was lower in our patients with LGSAS in comparison with patients with HGSAS and moderate AS, and was related to abnormalities of ventricular afterload. Although both Ea and Ca are calculated measures that incorporate stroke volume, SVRI, a measure that uses cardiac index rather than stroke volume index, also was closely related to stroke volume index. Furthermore, aortic pulse pressure correlated with stroke volume index, demonstrating the relationship between arterial compliance and flow. The present study has implications for defining the severity of aortic stenosis in the context of ventricular afterload, in addition to the traditional method of defining severity through valve lesion severity (ie, peak velocity or gradient and valve area) and the pathological response of the left ventricle. Of note, patients with LGSAS tended to have milder LV hypertrophy despite having a higher global afterload in comparison with patients with HGSAS. This observation also has been noted in previous studies, and might reflect an inherent predisposition toward concentric remodeling rather than myocardial hypertrophy in response to elevations in impedance. 18, 19 Cardiac dimensions and EF were similar between groups despite lower stroke volume in LGSAS, which may be related to limitations in noninvasive assessment of EF and pronounced chamber remodeling observed in patients with LGSAS. Intrinsic myocardial dysfunction, despite preservation of LV systolic function, has been demonstrated in LGSAS 3, 4, 18, 20 and myocardial fibrosis may be more prominent in this group. 21 To investigate the relative effects of intrinsic myocardial dysfunction and arterial afterload on total afterload, we examined circumferential end-systolic wall stress and found that it was similar in the groups with LGSAS and HGSAS and lower, as expected, in the group with moderate AS. This finding suggests that arterial afterload is a major contributor to the lower stroke volume in patients with LGSAS.
Aortic systolic pressure was higher in the group with LGSAS compared with HGSAS, indicating that systemic hypertension may contribute to elevated Ea. Systemic hypertension is common in patients with LGSAS 22 and is known to accelerate age-related arterial stiffening. Myocardial contractility generally increases in response to increases in arterial afterload related to hypertension 23 ; however, this response is impaired in patients with heart failure and preserved EF. 24 Calcific aortic stenosis is not only a disease of a valve, but also of the entire vascular tree, and alterations in LV function may exist not only because of the aortic valvular disease, but also because of hypertension and concomitant coronary artery disease. 25 Both systemic hypertension and elevated arterial afterload seem to be important components that contribute to the LGSAS syndrome.
Recent studies have recognized the impaired survival of patients with LGSAS, yet there is no clear consensus on the appropriate clinical management of this entity. The recognition of abnormalities of LV afterload in the present study is noteworthy because elevated peripheral resistance might represent a therapeutic target with medical therapy. Further studies to define goals of therapy, including the role of afterload reduction and surgical relief of aortic stenosis, in patients with LGSAS are required.
Limitations
Study and comparison groups represent consecutive patients who were referred for invasive hemodynamic catheterization during the same time period and, despite similar demographic characteristics, selection bias may be present because of the retrospective nature of the study. We attempted to address this potential bias by including all patients who underwent cardiac catheterization for aortic stenosis during the same time period.
Conclusions
Patients with LGSAS and preserved EF display elevated Ea and peripheral arterial resistance and lower arterial compliance compared with patients with HGSAS. These findings identify systemic arterial effects that contribute to the hemodynamic presentation in patients with LGSAS and help to further define this entity.
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Abnormalities of arterial circulation are proposed to be a major contributor to the syndrome of low flow, low gradient severe aortic stenosis (AS) with preserved ejection fraction based on data from noninvasive studies. This study invasively examined systemic arterial afterload (effective arterial elastance, total arterial compliance, and systemic vascular resistance index) in patients with low gradient severe AS (mean gradient, <40 mm Hg; aortic valve area, <1.0 cm 2 ) and preserved ejection fraction (≥50%), and compared these findings with patients with high gradient (≥40 mm Hg) severe AS and moderate AS (mean gradient <40 mm Hg; aortic valve area >1.0 cm ; P=0.001), were significantly higher in LGSAS, whereas total arterial compliance was lower (0.46±0.16 versus 0.57±0.13 and 0.59±0.19 mL/ m 2 per mm Hg; P=0.002). Additionally, all afterload measures were associated with stroke volume index. These results provide confirmation that systemic arterial effects contribute to the hemodynamic presentation in patients with low gradient severe AS, helping to further define this entity.
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